Evidence map›Paper›PMID 30230809›Full record

ArticleACS applied materials & interfaces2018

Untemplated Resveratrol-Mediated Polydopamine Nanocapsule Formation.

Devang R Amin, Cody J Higginson, Angie B Korpusik, Alyse R Gonthier, Phillip B Messersmith

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. The Sirt1-Piezo1 Axis Promotes Bone Formation and Repair in Mice.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Multifunctional polydopamine - ZnBiomaterials advances · 2023
    Article
  7. Review
  8. Review
  9. Versatile Polymer Nanocapsules via Redox Competition.Angewandte Chemie (International ed. in English) · 2021
    Article
  10. Review
  11. Article
  12. Nanomaterials for Cardiac Tissue Engineering.Molecules (Basel, Switzerland) · 2020
    Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Devang R AminDepartments of Bioengineering and Materials Science and Engineering , University of California, Berkeley , 210 Hearst Mining Building , Berkeley , California 94720 , United States.
Cody J HigginsonDepartments of Bioengineering and Materials Science and Engineering , University of California, Berkeley , 210 Hearst Mining Building , Berkeley , California 94720 , United States.
Angie B KorpusikDepartments of Bioengineering and Materials Science and Engineering , University of California, Berkeley , 210 Hearst Mining Building , Berkeley , California 94720 , United States.
Alyse R GonthierDepartments of Bioengineering and Materials Science and Engineering , University of California, Berkeley , 210 Hearst Mining Building , Berkeley , California 94720 , United States.
Phillip B MessersmithDepartments of Bioengineering and Materials Science and Engineering , University of California, Berkeley , 210 Hearst Mining Building , Berkeley , California 94720 , United States.ORCID http://orcid.org/0000-0002-1197-333X
Hearst (United States) · USLawrence Berkeley National Laboratory · USNorthwestern University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM008152 · NIGMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ARDEHALI, HOSSEIN · 1987 to 2021
$24.0M
Developing Capacity to Evaluate Training Programs via Development of Human, Institutional and Social CapitalT32GM008449 · NIGMS · NORTHWESTERN UNIVERSITY · PI LEONARD, JOSHUA NATHANIEL · 1993 to 2023
$7.8M
Proposal for Central California 900 MHZ NMR SpectrometerP41GM068933 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI WEMMER, DAVID E · 2003 to 2007
$5.9M
Biologically Inspired Polymer AdhesivesR37DE014193 · NIDCR · UNIVERSITY OF CALIFORNIA BERKELEY · PI MESSERSMITH, PHILLIP B · 2006 to 2015
$3.5M
NIDCR NIH HHS R37 DE014193NIGMS NIH HHS P41 GM068933NIGMS NIH HHS T32 GM008152NIGMS NIH HHS T32 GM008449
6 · The paper itself

Abstract

Nanocapsules can be designed for applications including drug delivery, catalysis, and biological imaging. The mussel-inspired material polydopamine is a promising shell layer for nanocapsules because of its free radical scavenging capacity, ability to react with a broad range of functional molecules, lack of toxicity, and biodegradability. Previous reports of polydopamine nanocapsule formation have relied on a templating approach. Herein, we report a template-free approach to polydopamine nanocapsule formation in the presence of resveratrol, a naturally occurring anti-inflammatory and antioxidant compound found in red wine and grapes. Synthesis of nanocapsules occurs spontaneously in an ethanolic resveratrol/dopamine·HCl solution at pH 8.5. UV-vis absorbance spectroscopy and X-ray photoelectron spectroscopy indicate that resveratrol is incorporated into the nanocapsules. We also observed the formation of a soluble fluorescent dopamine-resveratrol adduct during synthesis, which was identified by high-performance liquid chromatography, UV-vis spectroscopy, and electrospray ionization mass spectrometry. Using transmission electron microscopy and dynamic light scattering, we studied the influence of solvent composition, dopamine concentration, and resveratrol/dopamine ratio on the nanocapsule diameter and shell thickness. The resulting nanocapsules have excellent free radical scavenging activity as measured by a 2,2-diphenyl-1-picrylhydrazyl radical scavenging assay. Our work provides a convenient pathway by which resveratrol, and possibly other hydrophobic bioactive compounds, may be encapsulated within polydopamine nanocapsules.

Indexed as

capsuledopaminenanocapsulenanoparticlepolydopamineresveratrol

Identifiers

PMID30230809
PMCPMC6320237
OpenAlexW2890859997

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.